Loading...
 
Translate Register Log In Login with facebookLogin and Register

Eczema (Atopic Dermatitis) treated by 1,600 IU Vitamin D (again) – Meta-analysis Aug 2019

Vitamin D Deficiency and Effects of Vitamin D Supplementation on Disease Severity in Patients with Atopic Dermatitis: A Systematic Review and Meta-Analysis in Adults and Children

Sonal R Hattangdi-Haridas 1, Susan A Lanham-New 1, Wilfred Hing Sang Wong 2, Marco Hok Nutrients 2019, 11(8), 1854; https://doi.org/10.3390/nu11081854 (registering DOI)

 Download the PDF from VitaminDWiki
Image

Kung Ho 2 and Andrea L Darling 1,*

  • 1 Department of Nutritional Sciences, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
  • 2 Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

Research has investigated 25-hydroxyvitamin D (25(OH)D) levels in the Atopic Dermatitis (AD) population, as well as changes in AD severity after vitamin D (VitD) supplementation. We performed an up-to-date systematic review and meta-analysis of these findings. Electronic searches of MEDLINE, EMBASE and COCHRANE up to February 2018 were performed. Observational studies comparing 25(OH)D between AD patients and controls, as well as trials documenting baseline serum 25(OH)D levels and clinical severity by either SCORAD/EASI scores, were included. Of the 1085 articles retrieved, sixteen were included. A meta-analysis of eleven studies of AD patients vs. healthy controls (HC) found a mean difference of −14 nmol/L (95% CI −25 to −2) for all studies and −16 nmol/L (95% CI −31 to −1) for the paediatric studies alone. A meta-analysis of three VitD supplementation trials found lower SCORAD by −11 points (95% CI −13 to −9, p < 0.00001). This surpasses the Minimal Clinical Important Difference for AD of 9.0 points (by 22%). There were greater improvements in trials lasting three months and the mean weighted dose of all trials was 1500–1600 IU/daily. Overall, the AD population, especially the paediatric subset, may be at high-risk for lower serum 25(OH)D. Supplementation with around 1600 IU/daily results in a clinically meaningful AD severity reduction.

Created by admin. Last Modification: Friday August 9, 2019 14:45:06 GMT-0000 by admin. (Version 3)

Attached files

ID Name Comment Uploaded Size Downloads
12445 Atopic table 4.jpg admin 09 Aug, 2019 14:41 31.83 Kb 54
12444 Atopic Meta.pdf PDF 2019 admin 09 Aug, 2019 14:41 419.97 Kb 25
See any problem with this page? Report it (FINALLY WORKS)